Overview
D&D-seq is a newly developed technology designed to map DNA binding sites for transcription factors and other regulatory proteins within individual cells. This method is compatible with multi-omics analysis, indicating its utility for comprehensive cellular investigations. The technology was developed by investigators at Weill Cornell Medicine and the New York Genome Center.
Research Context
Gene activity in cells is controlled, in part, by transcription factors and other regulatory proteins that bind to specific sites on DNA. Understanding these DNA-protein interactions at a single-cell resolution is crucial for dissecting the mechanisms of gene regulation. The D&D-seq technology aims to provide a tool for scientists to study these interactions, particularly when seeking to understand cells in both healthy and diseased states.
The established methods for mapping DNA-protein interactions possess certain characteristics. D&D-seq is described as having key advantages over these currently utilized techniques, suggesting improvements in efficiency, resolution, or breadth of application, particularly concerning single-cell and multi-omics compatibility.
Findings
- D&D-seq maps DNA binding sites of transcription factors.
- D&D-seq maps DNA binding sites of other regulatory proteins.
- The mapping occurs in single cells.
- The technology is compatible with multi-omics approaches.
Why This Matters
This technology is expected to become an important addition to the toolkit available to biologists. It offers the potential for detailed studies on how gene activity is controlled, which is relevant for investigating cellular functions in health and disease scenarios.
Research Source
Weill Cornell Medicine and the New York Genome Center